相似文献
1
Slit/Robo pathway: a promising therapeutic target for cancer.
Drug Discov Today. 2015 Jan;20(1):156-64. doi: 10.1016/j.drudis.2014.09.008. Epub 2014 Sep 20.
2
The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers.
BMC Cancer. 2015 Dec 16;15:950. doi: 10.1186/s12885-015-1984-4.
3
The SLIT/ROBO Pathway in Liver Fibrosis and Cancer.
Biomolecules. 2023 May 1;13(5):785. doi: 10.3390/biom13050785.
4
The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system.
Reproduction. 2010 Apr;139(4):697-704. doi: 10.1530/REP-10-0017. Epub 2010 Jan 25.
5
Slit-Robo signaling.
Development. 2016 Sep 1;143(17):3037-44. doi: 10.1242/dev.132829.
6
Structure and Function of Roundabout Receptors.
Subcell Biochem. 2019;93:291-319. doi: 10.1007/978-3-030-28151-9_9.
7
Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression.
J Clin Invest. 2015 Nov 3;125(12):4407-20. doi: 10.1172/JCI81673.
8
Drosophila neurexin IV interacts with Roundabout and is required for repulsive midline axon guidance.
J Neurosci. 2010 Apr 21;30(16):5653-67. doi: 10.1523/JNEUROSCI.6187-09.2010.
9
Coevolution of axon guidance molecule Slit and its receptor Robo.
PLoS One. 2014 May 6;9(5):e94970. doi: 10.1371/journal.pone.0094970. eCollection 2014.
10
Slit/Robo Signaling Pathway in Cancer; a New Stand Point for Cancer Treatment.
Pathol Oncol Res. 2019 Oct;25(4):1285-1293. doi: 10.1007/s12253-018-00568-y. Epub 2019 Jan 4.
引用本文的文献
1
Molecular Subtypes and Risk Prediction Model Based on Malignant Cell Differentiation Trajectories in Breast Cancer.
J Cell Mol Med. 2025 Aug;29(15):e70680. doi: 10.1111/jcmm.70680.
2
Dissecting the biology of gliomagenesis: Evaluating the interaction between tumor mutation and germline variants.
Neurooncol Adv. 2025 Jul 8;7(1):vdaf147. doi: 10.1093/noajnl/vdaf147. eCollection 2025 Jan-Dec.
3
Knowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer.
Proteomes. 2025 May 29;13(2):20. doi: 10.3390/proteomes13020020.
4
SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling.
Open Life Sci. 2024 Oct 29;19(1):20220956. doi: 10.1515/biol-2022-0956. eCollection 2024.
5
Dysregulated gene subnetworks in breast invasive carcinoma reveal novel tumor suppressor genes.
Sci Rep. 2024 Jul 8;14(1):15691. doi: 10.1038/s41598-024-59953-0.
6
Slit1 inhibits ovarian follicle development and female fertility in mice†.
Biol Reprod. 2024 Oct 14;111(4):834-844. doi: 10.1093/biolre/ioae106.
7
Phenotypic targeting using magnetic nanoparticles for rapid characterization of cellular proliferation regulators.
Sci Adv. 2024 May 10;10(19):eadj1468. doi: 10.1126/sciadv.adj1468. Epub 2024 May 8.
8
Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy.
Circ Res. 2024 Mar 29;134(7):913-930. doi: 10.1161/CIRCRESAHA.122.321292. Epub 2024 Feb 27.
9
Molecular portraits of colorectal cancer morphological regions.
Elife. 2023 Nov 13;12:RP86655. doi: 10.7554/eLife.86655.
10
A parasite DNA binding protein with potential to influence disease susceptibility acts as an analogue of mammalian HMGA transcription factors.
PLoS One. 2023 Jun 5;18(6):e0286526. doi: 10.1371/journal.pone.0286526. eCollection 2023.
本文引用的文献
1
Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.
Carcinogenesis. 2014 Aug;35(8):1780-7. doi: 10.1093/carcin/bgu060. Epub 2014 Mar 6.
2
CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis.
PLoS One. 2014 Mar 4;9(3):e90400. doi: 10.1371/journal.pone.0090400. eCollection 2014.
3
Wnt modulates MCL1 to control cell survival in triple negative breast cancer.
BMC Cancer. 2014 Feb 24;14:124. doi: 10.1186/1471-2407-14-124.
4
PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy.
Int J Cancer. 2014 Sep 1;135(5):1257-63. doi: 10.1002/ijc.28769. Epub 2014 Feb 27.
5
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.
Breast Cancer Res. 2014 Jan 23;16(1):R12. doi: 10.1186/bcr3604.
6
Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer.
Br J Cancer. 2014 Mar 4;110(5):1288-97. doi: 10.1038/bjc.2014.1. Epub 2014 Jan 21.
7
Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer.
Cancer Res. 2014 Mar 1;74(5):1529-40. doi: 10.1158/0008-5472.CAN-13-1012. Epub 2014 Jan 21.
8
Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data.
Carcinogenesis. 2014 May;35(5):1039-45. doi: 10.1093/carcin/bgu010. Epub 2014 Jan 13.
9
Tumor-associated macrophages are correlated with tamoxifen resistance in the postmenopausal breast cancer patients.
Pathol Oncol Res. 2014 Jul;20(3):619-24. doi: 10.1007/s12253-013-9740-z. Epub 2014 Jan 12.
10
CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways.
Mol Biol Cell. 2014 Mar;25(5):566-82. doi: 10.1091/mbc.E13-07-0360. Epub 2014 Jan 8.
Zotero 插件